Princess® RICH for the Correction of Fine Lines

Inclusion criteria

• Subjects deemed by the treating physician to have LCL and/or PR of sufficient baseline severity to merit treatment with Princess® RICH to be corrected
• A negative urine pregnancy test at Visit 1 and commitment to use an adequate method of birth control for the duration of the clinical investigation (for women of childbearing potential only.)
• Healthy skin in the facial area and free of diseases that could interfere in cutaneous aging evaluation
• Willingness to abstain from any aesthetic or surgical procedures in the treatment area for the duration of the clinical investigation
• Written signed and dated informed consent

Exclusion criteria

• Tendency to hypertrophic scars, pigment disorders or keloid formation.
• History of autoimmune disease or receiving therapy for modification of immune response
• Hypersensitivity to hyaluronic acid or glycerol.
• Permanent fillers in the areas to be treated.
• Subjects who are pregnant or breast feeding.
• Subjects who are anticoagulated or with history of bleeding disorder.
• Daily treatment with platelet aggregation inhibitors unless previously cleared by their primary care physician.
• Cutaneous, inflammatory and/or infectious processes present at V0, recurrent herpes simplex or (pre) cancerous lesions in the areas to be treated
• Known Diabetes mellitus or uncontrolled systemic diseases in the assessment of the investigator.
• Laser therapy, chemical peeling, dermabrasion or botulin toxin treatment in the area to be treated within less than three months prior to and during the course of the study.
• Current participation in another clinical investigation
• Subjects whose participation in clinical trials is prohibited by the Austrian Medical Devices Act (e.g, persons with a legal custodian appointed due to mental disability, prisoners, soldiers and other members of the armed forces, civil servants)